DADATA·ANALYSIS
FREE
company · cik 1006281

Protalix BioTherapeutics, Inc.

PLXNYSESIC 2836public
financials · annual · usd2026
Revenue$52.7M
Net income-$6.6M
Total assets$82.3M
Total liabilities$34.1M
Equity$48.2M
LT debt$912.0K
Operating cash-$12.0M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1